SGX Announcements

SGX Announcements By Year: All | 2020 | 2019 | 2018

16 Nov 2020 General Announcement: Results Briefing 3Q2020
12 Nov 2020 Hyphens Pharma Broadens Ceradan Brand’s Outreach to Mainland China
11 Nov 2020 Financial Statements and Related Announcement: Third Quarter Results
05 Nov 2020 General Announcement: Change in Composition of the Board of Directors and Board Committees
05 Nov 2020 Announcement of Appointment: Appointment of an Independent Non-Executive Director
03 Nov 2020 Hyphens Pharma Expands Ocean Health Distribution to Sri Lanka
03 Sep 2020 Corporate Presentation
18 Aug 2020 Intangible Asset Portfolio Review
18 Aug 2020 General Announcement: Results Briefing 2Q2020
17 Aug 2020 Hyphens Pharma Inks Exclusive Partnership with SUTL to Distribute Ocean Health Products
13 Aug 2020 Financial Statements and Related Announcement: Second Quarter and/or Half Yearly Results
03 Aug 2020 Corporate Presentation at ASEAN Regional Healthcare Conference by DBS
03 Aug 2020 Hyphens Pharma Expands Proprietary Brands Portfolio with Hair Loss Products
24 Jul 2020 Change of Director’s Interest – Mr Tan Chwee Choon
22 Jul 2020 Change of Director’s Interest – Mr Tan Chwee Choon
15 Jul 2020 Change of Director’s Interest – Mr Tan Chwee Choon
13 Jul 2020 Hyphens Pharma Receives UK Patent for Ceradan Advanced
24 Jun 2020 Change of Director’s Interest – Mr Tan Chwee Choon
12 Jun 2020 Results and Minutes of Annual General Meeting held on 12 June 2020
08 Jun 2020 Response to Queries from SIAS on Annual Report 2019
02 Jun 2020 Change of Director’s Interest – Mr Tan Chwee Choon
01 Jun 2020 Change of Director’s Interest – Mr Tan Chwee Choon
26 May 2020 Sustainability Report 2019
21 May 2020 Notice of Annual General Meeting
14 May 2020 General Announcement: Results Briefing 1Q2020
11 May 2020 Cash Dividend / Distribution: Mandatory
11 May 2020 General Announcement: Update on FY2019 Proposed Final Dividend of S$0.01 per Share
11 May 2020 Financial Statements and Related Announcement: First Quarter Results
28 Apr 2020 Response to Query Regarding Trading Activity
27 Apr 2020 General Announcement – Voluntary Continuation of Quarterly Reporting and Deferment of Half-Yearly Reporting
17 Apr 2020 General Announcement: Change in Composition of the Board of Directors and Board Committees
17 Apr 2020 Announcement of Cessation: Resignation of an Independent Director
09 Apr 2020 General Announcement: Business Continuity During Covid-19 Pandemic
08 Apr 2020 Waiver: Extension of Time to Hold Annual General Meeting for Financial Year Ended 31 December 2019
08 Apr 2020 Annual Reports and Related Documents
03 Mar 2020 General Announcement: Hyphens Results Briefing FY2019
26 Feb 2020 Financial Statements and Related Announcement: Full Yearly Results
06 Feb 2020 General Announcement: TDF Fairence T-Complex has efficacy tests affirmed in Journal of Cosmetic Dermatology
17 Dec 2019 General Announcement: Hyphens Pharma inks Research Collaboration Agreement with the Institute of Chemical and Engineering Sciences
19 Nov 2019 General Announcement: Hyphens Results Briefing 3Q2019
14 Nov 2019 Financial Statements and Related Announcement: Third Quarter Results
05 Nov 2019 Announcement of Cessation: Resignation of General Manager
30 Aug 2019 Announcement of Appointment: Appointment of Chief Operating Officer
19 Aug 2019 General Announcement: Hyphens Results Briefing 2Q2019
13 Aug 2019 Financial Statements and Related Announcement: Second Quarter and/or Half Yearly Results
29 Jul 2019 Announcement of Appointment: Appointment of an Independent Non-Executive Director
22 Jul 2019 General Announcement: Ocean Health revamped, unveils new and refreshed look
10 Jul 2019 General Announcement: Hyphens Pharma launches New Ceradan Advanced
17 Jun 2019 General Announcement: Hyphens Pharma first to introduce bioabsorbable metallic implants to Vietnam
30 May 2019 General Announcement: Hyphens Pharma Signs Exclusive Distribution Agreement with Lundbeck for Vietnam
17 May 2019 General Announcement: Corporate Presentations – Hyphens Results Briefing 1Q2019
17 May 2019 General Announcement: Corporate Presentations – Hyphens Presentation Deck
17 May 2019 General Announcement: Corporate Presentations
15 May 2019 Employee Stock Option/Share Scheme: Grant of Share Awards Pursuant to the Hyphens Share Plan
13 May 2019 Financial Statements and Related Announcement: First Quarter Results
26 Apr 2019 Annual General Meeting: Results and Presentation Slides
18 Apr 2019 Asset Acquisitions and Disposals: Striking-Off Of Indirect Wholly-Owned Subsidiary – Ocean Healthcare (M) Sdn. Bhd.
10 Apr 2019 Notice of Annual General Meeting
10 Apr 2019 Annual Reports and Related Documents
10 Apr 2019 Cash Dividend/Distribution: Mandatory
21 Mar 2019 General Announcement: Hyphens Pharma Officially Opens Corporate Headquarters and Integrated Facility
06 Mar 2019 General Announcement: Hyphens Results Briefing 4Q2018 / FY2018
28 Feb 2019 Financial Statements and Related Announcement: Full Yearly Results
18 Feb 2019 General Announcement: Hyphens Pharma appoints Industry Veteran to head Dermatology Business Unit
05 Dec 2018 General Announcement: Entry into Memorandum of Understanding with Doctor Anywhere
13 Nov 2018 Financial Statements and Related Announcement: Third Quarter Results
29 Sep 2018 Change in Corporate Information: Change of Registered Office
29 Aug 2018 General Announcement: Corporate Presentation at INVEST Fair 2018
10 Aug 2018 Financial Statements and Related Announcement: Second Quarter and/or Half Yearly Results
23 May 2018 General Announcement: Tenancy Agreement with RBC Investor Services Trust Singapore Limited
18 May 2018 General Announcement: Balloting Result under Public Offer of Related Persons
18 May 2018 Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer: Disclosure of interest by Executive Chairman and CEO – Mr Lim See Wah
18 May 2018 Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer: Disclosure of interest by Executive Director – Mr Tan Chwee Choon
18 May 2018 Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer: Disclosure of interest by Non-Executive Director – Dr Tan Kia King
18 May 2018 Disclosure of Interest/Changes in Interest of Substantial Shareholder(s)/Unitholder(s): Disclosure of interest by substantial shareholder – Inomed Holding Pte Ltd
18 May 2018 General Announcement: Hyphens Pharma International Makes Strong Listing Debut on the Catalist Board of the SGX-ST
17 May 2018 Equity – Listing Confirmation: Admission of 300,000,000 ordinary shares to the Official List of SGX-Catalist
17 May 2018 General Announcement: Balloting Results
16 Nov 2020 General Announcement: Results Briefing 3Q2020
12 Nov 2020 Hyphens Pharma Broadens Ceradan Brand’s Outreach to Mainland China
11 Nov 2020 Financial Statements and Related Announcement: Third Quarter Results
05 Nov 2020 General Announcement: Change in Composition of the Board of Directors and Board Committees
05 Nov 2020 Announcement of Appointment: Appointment of an Independent Non-Executive Director
03 Nov 2020 Hyphens Pharma Expands Ocean Health Distribution to Sri Lanka
03 Sep 2020 Corporate Presentation
18 Aug 2020 Intangible Asset Portfolio Review
18 Aug 2020 General Announcement: Results Briefing 2Q2020
17 Aug 2020 Hyphens Pharma Inks Exclusive Partnership with SUTL to Distribute Ocean Health Products
13 Aug 2020 Financial Statements and Related Announcement: Second Quarter and/or Half Yearly Results
03 Aug 2020 Corporate Presentation at ASEAN Regional Healthcare Conference by DBS
03 Aug 2020 Hyphens Pharma Expands Proprietary Brands Portfolio with Hair Loss Products
24 Jul 2020 Change of Director’s Interest – Mr Tan Chwee Choon
22 Jul 2020 Change of Director’s Interest – Mr Tan Chwee Choon
15 Jul 2020 Change of Director’s Interest – Mr Tan Chwee Choon
13 Jul 2020 Hyphens Pharma Receives UK Patent for Ceradan Advanced
24 Jun 2020 Change of Director’s Interest – Mr Tan Chwee Choon
12 Jun 2020 Results and Minutes of Annual General Meeting held on 12 June 2020
08 Jun 2020 Response to Queries from SIAS on Annual Report 2019
02 Jun 2020 Change of Director’s Interest – Mr Tan Chwee Choon
01 Jun 2020 Change of Director’s Interest – Mr Tan Chwee Choon
26 May 2020 Sustainability Report 2019
21 May 2020 Notice of Annual General Meeting
14 May 2020 General Announcement: Results Briefing 1Q2020
11 May 2020 Cash Dividend / Distribution: Mandatory
11 May 2020 General Announcement: Update on FY2019 Proposed Final Dividend of S$0.01 per Share
11 May 2020 Financial Statements and Related Announcement: First Quarter Results
28 Apr 2020 Response to Query Regarding Trading Activity
27 Apr 2020 General Announcement – Voluntary Continuation of Quarterly Reporting and Deferment of Half-Yearly Reporting
17 Apr 2020 General Announcement: Change in Composition of the Board of Directors and Board Committees
17 Apr 2020 Announcement of Cessation: Resignation of an Independent Director
09 Apr 2020 General Announcement: Business Continuity During Covid-19 Pandemic
08 Apr 2020 Waiver: Extension of Time to Hold Annual General Meeting for Financial Year Ended 31 December 2019
08 Apr 2020 Annual Reports and Related Documents
03 Mar 2020 General Announcement: Hyphens Results Briefing FY2019
26 Feb 2020 Financial Statements and Related Announcement: Full Yearly Results
06 Feb 2020 General Announcement: TDF Fairence T-Complex has efficacy tests affirmed in Journal of Cosmetic Dermatology
17 Dec 2019 General Announcement: Hyphens Pharma inks Research Collaboration Agreement with the Institute of Chemical and Engineering Sciences
19 Nov 2019 General Announcement: Hyphens Results Briefing 3Q2019
14 Nov 2019 Financial Statements and Related Announcement: Third Quarter Results
05 Nov 2019 Announcement of Cessation: Resignation of General Manager
30 Aug 2019 Announcement of Appointment: Appointment of Chief Operating Officer
19 Aug 2019 General Announcement: Hyphens Results Briefing 2Q2019
13 Aug 2019 Financial Statements and Related Announcement: Second Quarter and/or Half Yearly Results
29 Jul 2019 Announcement of Appointment: Appointment of an Independent Non-Executive Director
22 Jul 2019 General Announcement: Ocean Health revamped, unveils new and refreshed look
10 Jul 2019 General Announcement: Hyphens Pharma launches New Ceradan Advanced
17 Jun 2019 General Announcement: Hyphens Pharma first to introduce bioabsorbable metallic implants to Vietnam
30 May 2019 General Announcement: Hyphens Pharma Signs Exclusive Distribution Agreement with Lundbeck for Vietnam
17 May 2019 General Announcement: Corporate Presentations – Hyphens Results Briefing 1Q2019
17 May 2019 General Announcement: Corporate Presentations – Hyphens Presentation Deck
17 May 2019 General Announcement: Corporate Presentations
15 May 2019 Employee Stock Option/Share Scheme: Grant of Share Awards Pursuant to the Hyphens Share Plan
13 May 2019 Financial Statements and Related Announcement: First Quarter Results
26 Apr 2019 Annual General Meeting: Results and Presentation Slides
18 Apr 2019 Asset Acquisitions and Disposals: Striking-Off Of Indirect Wholly-Owned Subsidiary – Ocean Healthcare (M) Sdn. Bhd.
10 Apr 2019 Notice of Annual General Meeting
10 Apr 2019 Annual Reports and Related Documents
10 Apr 2019 Cash Dividend/Distribution: Mandatory
21 Mar 2019 General Announcement: Hyphens Pharma Officially Opens Corporate Headquarters and Integrated Facility
06 Mar 2019 General Announcement: Hyphens Results Briefing 4Q2018 / FY2018
28 Feb 2019 Financial Statements and Related Announcement: Full Yearly Results
18 Feb 2019 General Announcement: Hyphens Pharma appoints Industry Veteran to head Dermatology Business Unit
05 Dec 2018 General Announcement: Entry into Memorandum of Understanding with Doctor Anywhere
13 Nov 2018 Financial Statements and Related Announcement: Third Quarter Results
29 Sep 2018 Change in Corporate Information: Change of Registered Office
29 Aug 2018 General Announcement: Corporate Presentation at INVEST Fair 2018
10 Aug 2018 Financial Statements and Related Announcement: Second Quarter and/or Half Yearly Results
23 May 2018 General Announcement: Tenancy Agreement with RBC Investor Services Trust Singapore Limited
18 May 2018 General Announcement: Balloting Result under Public Offer of Related Persons
18 May 2018 Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer: Disclosure of interest by Executive Chairman and CEO – Mr Lim See Wah
18 May 2018 Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer: Disclosure of interest by Executive Director – Mr Tan Chwee Choon
18 May 2018 Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer: Disclosure of interest by Non-Executive Director – Dr Tan Kia King
18 May 2018 Disclosure of Interest/Changes in Interest of Substantial Shareholder(s)/Unitholder(s): Disclosure of interest by substantial shareholder – Inomed Holding Pte Ltd
18 May 2018 General Announcement: Hyphens Pharma International Makes Strong Listing Debut on the Catalist Board of the SGX-ST
17 May 2018 Equity – Listing Confirmation: Admission of 300,000,000 ordinary shares to the Official List of SGX-Catalist
17 May 2018 General Announcement: Balloting Results